We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Technique Restores Fertility to Patients with Fibroids

By MedImaging International staff writers
Posted on 19 Jun 2017
Print article
Image: The digital subtraction angiography images show the progress of partial Uterine Fibroid Embolization (UFE) treatments (Photo courtesy of RSNA).
Image: The digital subtraction angiography images show the progress of partial Uterine Fibroid Embolization (UFE) treatments (Photo courtesy of RSNA).
Researchers have shown that Uterine Fibroid Embolization (UFE) treatments can enable women suffering from uterine fibroids to become pregnant again.

Uterine fibroids often cause infertility and complications during pregnancy, and current standard treatments consist of surgery to remove the fibroids that may cause complications such as hysterectomy, and is not always effective. UFE treatments on the other hand are not yet fully accepted for fertility-preserving treatment in women with symptomatic fibroids.

The researchers from the Department of Interventional Radiology at the Saint Louis Hospital (Lisbon, Portugal) registered the pregnancy rates of 359 women with fertility problems who suffered from uterine fibroids, for a period of nearly six years. All of the women had undergone either partial or conventional UFE treatment. The study was published online in the June 2017 issue of the journal Radiology.

The results of the research showed that 149 women (41.5%) in the study group became pregnant at least once during the 6-year study period. The clinicians used Magnetic Resonance Imaging (MRI) scans and digital subtraction angiography imaging to visualize partial UFE.

Study co-author João Martins Pisco, MD, PhD, from the Department of Interventional Radiology at Saint Louis Hospital in Lisbon, Portugal, said, “Our findings show that UFE is a fertility-restoring procedure in women with uterine fibroids who wish to conceive, and pregnancy following UFE appears to be safe with low morbidity. Women who had been unable to conceive had normal pregnancies after UFE and similar complication rates as the general population in spite of being in a high-risk group. In our study there are now almost 200 newborns following UFE. Our next step will be a randomized study comparing the results of partial and conventional UFE."

Related Links:
Saint Louis Hospital

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
MRI System
uMR 588
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.